Trade War

Amgen's Juncos expansion strengthens Puerto Rico's role in global medicine supply

Amgen has added US$300 million to its announced Puerto Rico investment plans. Its Juncos plant supplies more than 60 countries, linking US manufacturing capacity with overseas medicine markets.

Companies and supply chains 17 November 2026

Amgen announced an additional US$300 million investment in its Puerto Rico manufacturing operations on 4 May 2026, following an earlier US$650 million commitment. The company's Juncos plant produces biological medicines distributed to more than 60 countries. The expansion links increased manufacturing capacity in a US territory with a global customer base.1

These are announced investment commitments, rather than a statement that all the additional equipment is already producing medicines. Amgen presented the project as part of its wider US manufacturing expansion, alongside investments in other locations.1

Puerto Rico supplies skills as well as factory space

Puerto Rico's economic-development department says the expansion supports more than 2,300 existing Amgen jobs on the island, as well as workforce development and new manufacturing technology. It identifies the Juncos operation as part of Puerto Rico's foreign-trade-zone programme since 2009. These are established industrial operations being expanded, rather than a first entry by the company.2

In its Spanish-language account, the department says the investment will:

fortalecerá la resiliencia de la cadena de suministro

Strengthen supply-chain resilience.2

That is the government's stated objective. More production capacity can support supply, but the department's announcement does not quantify the additional annual volume of medicines or assign it to particular buyer countries. Those details matter when translating an investment total into an expected change in trade.2

Company demand and territorial exports measure different things

Amgen's results released on 3 November 2026 provide a more recent picture of demand across its business. Third-quarter revenue reached US$10.4 billion, up 8% from the same quarter of 2025, and the company reported product-sales growth driven by higher volumes. Those are global company figures, not Juncos production or Puerto Rican export receipts.3

The same disclosure highlights manufacturing concentration as a business risk. Amgen says a substantial share of its commercial manufacturing occurs at a few key facilities, including Puerto Rico, and that it also depends on outside manufacturers. Supply constraints can therefore affect sales even where demand for medicines remains strong, or disrupt development of future products.3

Puerto Rico's own fiscal-year 2026 trade summary adds a different perspective. Total recorded exports were about US$59.71 billion, down 1.61%, while imports fell faster. The larger trade surplus consequently did not mean exports had grown. The institute's territorial trade series includes shipments to the mainland United States, which accounted for 80% of the recorded export value.4

Its China figures identify about US$246.91 million in exports of medicines packaged in measured doses. Those totals cover the relevant trade category across Puerto Rico; the report does not attribute them to Amgen.4

The open question for the Juncos project is when the announced expansion becomes operating capacity, and which additional customer markets that capacity will serve.1

Sources

  1. Amgen. Amgen Announces Additional $300 Million U.S. Manufacturing Investment, Totaling Nearly $2 Billion Over the Last Year. 4 May 2026Industry camp · company announcement
  2. DDEC. Amgen continúa fortaleciendo su presencia en Puerto Rico con una inversión adicional de $300 millones en Juncos [Amgen strengthens its Puerto Rico presence with an additional $300 million in Juncos]. Accessed 17 November 2026Puerto Rico's camp · government · in Spanish
  3. Amgen. Amgen Reports Third Quarter 2026 Financial Results. 3 November 2026Industry camp · company results
  4. Instituto de Estadísticas de Puerto Rico. Informe Estadístico a la Gobernadora - Comercio Exterior año fiscal 2026 [Statistical report to the governor: foreign trade in fiscal year 2026]. 24 August 2026Puerto Rico's camp · government statistics · in Spanish

All articles